Shares of Sun Pharma continued its gains from Friday, rising over a percent on Monday morning, after its Halol plant received a VAI status from US drug regulator. The status implies that the plant may not go a re-inspection by the regulator ahead.
The stock has touched an intraday high of Rs 536.00 and an intraday low of Rs 527.70.
The company has received a voluntary action initiated (VAI) status for its Halol plant from US FDA.
For the uninitiated, VAI status would imply that there would be no re-inspection required at its Halol unit.
The US Food and Drug Administration (FDA) had issued three observations to the unit in February.
The drug major had last month posted around 7 percent increase in consolidated net profit at Rs 1,308.96 crore for the quarter ending March on the back of revenue growth in India and emerging markets even as the US sales took a hit.
At 09:30 hrs Sun Pharmaceutical Industries was quoting at Rs 530.00, up Rs 1.80, or 0.34 percent, on the BSE.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
